Takeda establishes new drug discovery subsidiary
Also transfers part of its pharmaceutical sciences businesses to Bushu
Read More
Author: Dominic Tyer
Triple trial boost for Lilly’s migraine drug
CGRP treatment galcanezumab looks to be course for regulatory submissions
Read More
NHS cyber attack – fallout continues
Cancellations and slower health services after 48 NHS Trusts hit by ransomware
Read More
NHS Confederation calls on government for health funding plan
The body presents case for 10 ‘asks’ before the snap election
Read More
Pfizer strikes gene therapy deal with Sangamo
Says one of the candidates included has best-in-class potential
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
